BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36528566)

  • 1. Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis.
    Zhang L; Cai H; Liu X; Xiong Y; Liang X; Shi J
    BMC Pregnancy Childbirth; 2022 Dec; 22(1):946. PubMed ID: 36528566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study.
    Chen M; Luo L; Wang Q; Gao J; Chen Y; Zhang Y; Zhou C
    Front Endocrinol (Lausanne); 2020; 11():318. PubMed ID: 32547490
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.
    Lan J; Wu Y; Wu Z; Wu Y; Yang R; Liu Y; Lin H; Jiao X; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():609771. PubMed ID: 34135858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
    Dong L; Lian F; Wu H; Xiang S; Li Y; Wei C; Yu X; Xin X
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):583. PubMed ID: 35869444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study.
    Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L
    Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
    Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
    Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF/ICSI: a systematic review and meta-analysis.
    Liu C; Tian T; Lou Y; Li J; Liu P; Li R; Qiao J; Wang Y; Yang R
    Expert Rev Mol Med; 2023 Dec; 26():e2. PubMed ID: 38095077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.
    Kadoura S; Alhalabi M; Nattouf AH
    Sci Rep; 2022 Mar; 12(1):4456. PubMed ID: 35292717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China.
    Yang J; Zhang X; Ding X; Wang Y; Huang G; Ye H
    Reprod Biol Endocrinol; 2021 Aug; 19(1):124. PubMed ID: 34384445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes after controlled ovarian hyperstimulation in women with endometriosis-associated infertility: GnRH-agonist versus GnRH-antagonist.
    Kolanska K; Cohen J; Bendifallah S; Selleret L; Antoine JM; Chabbert-Buffet N; Darai E; d'Argent EM
    J Gynecol Obstet Hum Reprod; 2017 Nov; 46(9):681-686. PubMed ID: 28970135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of hyperandrogenism on pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer].
    Jiang LL; Pan P; Jiao XD; Qiu Q; Li Y; Zhang QX
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(14):1042-1048. PubMed ID: 37032154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of uterine adenomyosis on clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET)].
    Tao T; Chen S; Chen X; Ye D; Xu L; Tian X; Liu Y; Niu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Feb; 35(2):248-51. PubMed ID: 25736122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.
    Zhang J; Sun YF; Xu YM; Shi BJ; Han Y; Luo ZY; Zhao ZM; Hao GM; Gao BL
    Front Endocrinol (Lausanne); 2021; 12():578783. PubMed ID: 34079517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 17. GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: A Retrospective Cohort Study on Clinical Outcomes and Maternal-Neonatal Safety.
    Zhu J; Xing W; Li T; Lin H; Ou J
    Front Endocrinol (Lausanne); 2022; 13():875779. PubMed ID: 35846307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer.
    Ding X; Yang J; Li L; Yang N; Lan L; Huang G; Ye H
    BMC Pregnancy Childbirth; 2021 Mar; 21(1):207. PubMed ID: 33711956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ovarian stimulation protocols on outcomes of assisted reproductive technology in adenomyosis women: a retrospective cohort study.
    Ge L; Li Y; Guan S; Cui L; Chen ZJ
    Front Endocrinol (Lausanne); 2023; 14():1198779. PubMed ID: 37664864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment.
    Hou X; Xing J; Shan H; Mei J; Sun Y; Yan G; Sun H; Wang J
    Reprod Biomed Online; 2020 Nov; 41(5):845-853. PubMed ID: 32972873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.